Astrocytoma: all 434 studies
Page 3 of 5. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.
- Investigational Imaging Technique During Brain SurgerySuspendedNCT05513859Not applicable
- Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaActive, not recruitingNCT05484622Phase 1
- Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant GliomasCompletedNCT05393258Not applicable
- Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent GlioblastomaWithdrawnNCT05341947Phase 1
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of GlioblastomaActive, not recruitingNCT05236036Phase 1
- Quality of Life and Patient Needs in Advanced High Grade GliomasCompletedNCT05039346
- A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaActive, not recruitingNCT04978727Phase 1
- Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed ModelsStatus unknownNCT04970615
- Role of Repeat Resection in Recurrent GlioblastomaWithdrawnNCT04838782Not applicable
- Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant GliomaTerminatedNCT04782609Phase 1
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV AstrocytomaCompletedNCT04757662Phase 1
- Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular AnalysisCompletedNCT04755023Phase 2
- Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical ResectionTerminatedNCT04608812Phase 1
- Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBMTerminatedNCT04489420Phase 1
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SCompletedNCT04430842Phase 1
- A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511TerminatedNCT04327011Phase 1
- Radiotherapy in IDH Mutated Glioma: Evaluation of Late OutcomesCompletedNCT04304300
- Genomic Landscape of Intramedullary AstrocytomaStatus unknownNCT04211974
- WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesActive, not recruitingNCT04197934Phase 1
- A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational BurdenActive, not recruitingNCT04145115Phase 2
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed GlioblastomaWithdrawnNCT04105374Phase 2/3
- Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With GlioblastomaCompletedNCT04091503Phase 1
- Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade GliomaActive, not recruitingNCT04065776Not applicable
- CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and GlioblastomaTerminatedNCT04047303Phase 1
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
- Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant GliomasWithdrawnNCT03956706Not applicable
- Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaActive, not recruitingNCT03919071Phase 2
- Social Determinants of Health in Glioblastoma PopulationCompletedNCT03900689
- Fimepinostat in Treating Brain Tumors in Children and Young AdultsActive, not recruitingNCT03893487Early Phase 1
- Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesTerminatedNCT03796273Early Phase 1
- Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
- Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant GliomaCompletedNCT03722355Phase 3
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsWithdrawnNCT03649464Phase 1/2
- Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade GliomaStatus unknownNCT03633552Phase 3
- A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent GliomasTerminatedNCT03593993
- 3D Prediction of Patient-Specific ResponseStatus unknownNCT03561207
- Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaActive, not recruitingNCT03528642Phase 1
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing RadiotherapyStatus unknownNCT03370926
- A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)CompletedNCT03355794Phase 1
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2TerminatedNCT03332355Phase 1
- International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)Status unknownNCT03243461Phase 3
- Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain TumorsActive, not recruitingNCT03220646Phase 2
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaActive, not recruitingNCT03180502Phase 2
- A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Active, not recruitingNCT03152318Phase 1
- Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological CharactersicsCompletedNCT03115164
- BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With BevacizumabCompletedNCT03020602Phase 1
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade GliomasWithdrawnNCT02976441Early Phase 1
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Neural Basis of Language ProcessingCompletedNCT02903784Not applicable
- Natural History of and Specimen Banking for People With Tumors of the Central Nervous SystemCompletedNCT02851706
- Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) PatientsStatus unknownNCT02796261Phase 3
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBMCompletedNCT02766699Phase 1
- Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine GliomaTerminatedNCT02758366Phase 2
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain TumorsCompletedNCT02747407
- Clinical Development of MR Spectroscopy and Imaging in Brain CancersCompletedNCT02731521
- Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) VaccineTerminatedNCT02722512Phase 1
- Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaCompletedNCT02709226Phase 1
- Radiomics for Prediction of Survival in GBMCompletedNCT02666066
- Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)TerminatedNCT02654340
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant GliomasStatus unknownNCT02629757Phase 3
- Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II GliomaCompletedNCT02549833Phase 1
- Fluorescein vs. iMRI in Resection of Malignant High Grade GliomaWithdrawnNCT02540135Not applicable
- Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed GlioblastomaTerminatedNCT02510950Phase 1
- A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade GliomaCompletedNCT02490930Early Phase 1
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsCompletedNCT02457845Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- The Addition of Chloroquine to Chemoradiation for Glioblastoma,WithdrawnNCT02432417Phase 2
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade GliomaTerminatedNCT02414165Phase 2/3
- Clinical Development of Cancer-Specific MRS Biomarkers in Malignant GliomasCompletedNCT02388659
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompletedNCT02238496Phase 1
- A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasStatus unknownNCT02209428Phase 2
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaCompletedNCT02101905Phase 1
- Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in GliomaStatus unknownNCT02077543Early Phase 1
- Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasWithdrawnNCT02055196Phase 1
- Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By SurgeryTerminatedNCT02031965Phase 1
- Immunophenotyping From Blood of Patients With Malignant GliomasCompletedNCT02022384
- Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent GlioblastomaCompletedNCT02010606Phase 1
- Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1
- 3T MRI Biomarkers of Glioma Treatment ResponseTerminatedNCT01996527Early Phase 1
- Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain TumorCompletedNCT01985256Phase 1
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsCompletedNCT01975116Phase 1
- Phase I Study of Safety and Immunogenicity of ADU-623CompletedNCT01967758Phase 1
- Valproic Acid in Childhood Progressive Brain TumorsWithdrawnNCT01861990Phase 1
- Evaluating the Expression Levels of MicroRNA-10b in Patients With GliomasTerminatedNCT01849952
- A Phase I Study of Mebendazole for the Treatment of Pediatric GliomasActive, not recruitingNCT01837862Phase 1/2
- Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVACompletedNCT01833273Phase 1
- Dendritic Cell (DC) Vaccine for Malignant Glioma and GlioblastomaCompletedNCT01808820Phase 1
- A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade GliomasStatus unknownNCT01765088Phase 3
- Re-irradiation of High Grade Gliomas: a Quality of Life StudyWithdrawnNCT01711580
- Phase-1 Study of Folinic Acid to Modulate MGMT Gene in GlioblastomaTerminatedNCT01700569Phase 1
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant GliomaStatus unknownNCT01656980Phase 3
- Efficacy of Tranexamic Acid in Brain Tumor ResectionsStatus unknownNCT01655927Phase 3
- Carboplatin in Treating Patients With Recurrent High-Grade GliomasCompletedNCT01644955Phase 1